Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Auragen receives breast cancer research grant

Nov. 15, 1996

Potent new antitumor agents revealed by Takeda

Nov. 15, 1996

IND filed in Canada for Neovastat

Nov. 15, 1996

Eisai discloses antitumor compounds

Nov. 15, 1996

Antineoplastic tyrosine kinase inhibitors disclosed by Thomae

Nov. 15, 1996

Promising clinical trial results on Taxotere presented at ESMO meeting

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

First alternative to 5-FU controls disease progression in colorectal cancer

Nov. 15, 1996

Gemzar introduced in Italy

Nov. 15, 1996

Phase II results with DaunoXome in non-Hodgkin's lymphoma

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...